The HIV-1 reverse transcriptase (RT) is an attractive target in the treatment of AIDS. This minireview focuses on the advances in the development of non-nucleoside RT inhibitors of the pyridin-2(1H)-one class. Representative molecules, covering several subclasses are presented. Computational studies, including automated docking and QSAR, are also discussed.
No takes yet. Share an insight, caveat, or question.
Medina‐Franco et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: